HMGB1 and peripheral arterial disease: We previously showed that elevated serum HMGB-1 levels were associated with the presence and the severity of PAD in diabetic patients, compared with diabetic patients without PAD [33]; however, an association between HMGB-1 and poor cardiovascular and limb outcomes after LER has not been demonstrated.